MSX2 and pancreatic neoplasm: Regarding the functional diversity of MSX2 in breast and pancreatic cancer (Satoh et al, 2008; Lanigan et al, 2010), DOX-inducible MSX2 over-expression systems (Wiznerowicz and Trono, 2003) were established in both WM793 and 1205Lu cells.